COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,763 Articles (22,502 medRxiv, 8,261 bioRxiv)

Most recent first Previous |  Page 1294: Articles 12931-12940  | Next

Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralising SARS-CoV-2 nanobodies
Hanke, L., Sheward, D. J., Pankow, A., Perez Vidakovics, L., Karl, V., Kim, C., Urgard, E., Smith, N. L., Astorga-Wells, J., Ekström, S., Coquet, J. M., McInerney, G. M., Murrell, B.
10.1101/2021.07.25.453673 — Posted: 2021-07-26
Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects Macaques from infection
Sulbaran, G., Maisonnasse, P., Amen, A., Guilligay, D., Bosquet, N., Burger, J. A., Poniman, M., Buisson, M., Dylon, S. D., Naninck, T., Lemaitre, J., Gros, W., Gallouet, A.-S., Marlin, R., Bouillier, C., Contreras, V., Relouzat, F., Fenel, D., Thepaut, M., Bally, I., Thielens, N., Fieschi, F., Schoehn, G., van der Werf, S., van Gils, M., Sandres, R. W., Poignard, P., Le Grand, R., Weissenhorn, W.
10.1101/2021.07.26.453755 — Posted: 2021-07-26
Differential Interactions Between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern
Kim, S., Liu, Y., Lei, Z., Dicker, J., Cao, Y., Zhang, X. F., Im, W.
10.1101/2021.07.23.453598 — Posted: 2021-07-26
Mutations in two SARS-CoV-2 variants of concern reflect two distinct strategies of antibody escape
Fiedler, S., Denninger, V., Morgunov, A. S., Ilsley, A., Worth, R., Meisl, G., Xu, C. K., Piziorska, M. A., Ricci, F., Malik, A. Y., Devenish, S. R. A., Schneider, M. M., Kosmoliaptsis, V., Aguzzi, A., Iwasaki, A., Fiegler, H., Knowles, T. P. J.
10.1101/2021.07.23.453327 — Posted: 2021-07-26
N-glycosylation profiles of the SARS-CoV-2 spike D614G mutant and its ancestral protein characterized by advanced mass spectrometry
Wang, D., Zhou, B., Keppel, T., Solano, M., Baudys, J., Goldstein, J., Finn, M. G., Fan, X., Chapman, A. P., Bundy, J., Woolfitt, A. R., Osman, S., Pirkle, J. L., Wentworth, D. E., Barr, J. R.
10.1101/2021.07.26.453787 — Posted: 2021-07-26
SARS-CoV-2 Delta variant pathogenesis and host response in Syrian hamsters
Mohandas, S., Yadav, P. D., Shete, A. A., Nyayanit, D., Sapkal, G. N., Lole, K., Gupta, N.
10.1101/2021.07.24.453631 — Posted: 2021-07-26
Protection afforded by the BNT162b2 and mRNA-1273 COVID-19 vaccines in fully vaccinated cohorts with and without prior infection
Abu-Raddad, L. J., Chemaitelly, H., Ayoub, H. H., YASSINE, H. M., Benslimane, F., Al Khatib, H. A., Tang, P., Hasan, M. R., Coyle, P., Al Kanaani, Z., Al Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G., Al Kuwari, M. G., Butt, A. A., Al Romaihi, H. E., Al-Thani, M. H., Al Khal, A., Bertollini, R.
10.1101/2021.07.25.21261093 — Posted: 2021-07-26 Discussion: Offsite
The U.S. COVID-19 Trends and Impact Survey, 2020-2021: Continuous real-time measurement of COVID-19 symptoms, risks, protective behaviors, testing and vaccination
Salomon, J. A., Reinhart, A., Bilinski, A., Chua, E. J., La Motte-Kerr, W., Rönn, M., Reitsma, M. B., Morris, K. A., LaRocca, S., Farag, T., Kreuter, F., Rosenfeld, R., Tibshirani, R.
10.1101/2021.07.24.21261076 — Posted: 2021-07-26
Novel risk factors for Coronavirus disease-associated mucormycosis (CAM): a case control study during the outbreak in India
Arora, U., Priyadarshi, M., Katiyar, V., Soneja, M., Garg, P., Gupta, I., Bharadiya, V., Berry, P., Ghosh, T., Patel, L., Sarda, R., Garg, S., Agarwal, S., Arora, V., Ramprasad, A., Kumar, A., Garg, R. K., Kodan, P., Nischal, N., Singh, G., Jorwal, P., Kumar, A., Baitha, U., Meena, V. P., Ray, A., Sethi, P., Xess, I., Vikram, N. K., Sinha, S., Biswas, A., Thakar, A., Bhatnagar, S., Trikha, A., Wig, N.
10.1101/2021.07.24.21261040 — Posted: 2021-07-26
COVID-Q: validation of the first COVID-19 questionnaire based on patient-rated symptom gravity
Spinato, G., Fabbris, C., Conte, F., Menegaldo, A., Franz, L., Gaudioso, P., Cinetto, F., Agostini, C., Costantini, G., Boscolo Rizzo, P.
10.1101/2021.07.24.21261065 — Posted: 2021-07-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).